PANCREATIC CANCER ACTION NETWORK ADAPTIVE CLINICAL TRIAL ADDS NEW INVESTIGATIONAL TREATMENT AND ADDITIONAL SITES

Investigational Treatment From Novartis To Be Activated At Precision PromiseSM Clinical Trial Sites Across the Country, Including Five Additional Premier Cancer Institutions LOS ANGELES, March 24, 2022 /PRNewswire/ — The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in…